Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Basiliximab plus low-dose corticosteroids versus thymoglobulin plus high-dose corticosteroids after pancreas transplantation
2012-005335-83Phase 4Completed
- Sponsor
- Oslo University Hospital
- Start
- Dec 2012
- Modality
- RNA-Targeting Small Molecules → Nucleic Acid-Directed Small Molecules → Small Molecules, Small Molecules, Antibody-Based Therapeutics
- Countries
- 1
01
Overview
A Phase 4 trial of basiliximab, antithymocyte globulin, tacrolimus, mycophenolate, corticosteroids in diabetes mellitus (DM), sponsored by Oslo University Hospital. Started Dec 2012; status: completed.
02
Drugs
basiliximabantithymocyte globulintacrolimusmycophenolatecorticosteroids
03
Conditions
diabetes mellitus (DM)
Beyond the preview
Go deeper on 2012-005335-83.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2012-005335-83.